Market Closed -
Euronext Paris
11:35:06 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
8.43
EUR
|
+4.46%
|
|
-0.24%
|
-26.95%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
114
|
68.66
|
57.65
|
58.24
|
33.82
|
120.5
|
120.5
|
-
|
Enterprise Value (EV)
1 |
81.31
|
46.15
|
57.73
|
77.56
|
33.82
|
162.1
|
97.95
|
58.15
|
P/E ratio
|
16.5
x
|
-3.67
x
|
-2.52
x
|
-2.53
x
|
-4.41
x
|
4.11
x
|
2.27
x
|
1.51
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.11
x
|
8.44
x
|
8.44
x
|
9.62
x
|
1.95
x
|
26.8
x
|
2.41
x
|
1.4
x
|
EV / Revenue
|
1.51
x
|
5.67
x
|
8.45
x
|
12.8
x
|
1.95
x
|
26.8
x
|
1.96
x
|
0.68
x
|
EV / EBITDA
|
7.56
x
|
-2.21
x
|
-2.88
x
|
-
|
-
|
12
x
|
3.75
x
|
1.32
x
|
EV / FCF
|
14.7
x
|
-3.95
x
|
-2.62
x
|
-3.96
x
|
-
|
14.1
x
|
3.63
x
|
1.41
x
|
FCF Yield
|
6.8%
|
-25.3%
|
-38.2%
|
-25.3%
|
-
|
7.11%
|
27.6%
|
70.7%
|
Price to Book
|
2.5
x
|
2.46
x
|
9.14
x
|
-
|
-
|
17.6
x
|
3.51
x
|
1.6
x
|
Nbr of stocks (in thousands)
|
6,895
|
6,935
|
6,946
|
7,190
|
8,519
|
14,289
|
14,289
|
-
|
Reference price
2 |
16.54
|
9.900
|
8.300
|
8.100
|
3.970
|
8.430
|
8.430
|
8.430
|
Announcement Date
|
3/12/19
|
3/12/20
|
3/18/21
|
4/19/22
|
3/15/23
|
4/24/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
53.93
|
8.134
|
6.833
|
6.055
|
17.36
|
6.048
|
50
|
86
|
EBITDA
1 |
10.75
|
-20.86
|
-20.02
|
-
|
-
|
10.3
|
26.1
|
44
|
EBIT
1 |
9.707
|
-22.02
|
-21.15
|
-19.37
|
-12.9
|
-14.24
|
24.1
|
40.6
|
Operating Margin
|
18%
|
-270.73%
|
-309.5%
|
-319.83%
|
-74.28%
|
-235.52%
|
48.2%
|
47.21%
|
Earnings before Tax (EBT)
|
-
|
-
|
-23.3
|
-22.75
|
-6.425
|
-
|
-
|
-
|
Net income
1 |
7.615
|
-18.6
|
-23.32
|
-22.75
|
-6.901
|
-21.16
|
26.6
|
40.1
|
Net margin
|
14.12%
|
-228.71%
|
-341.34%
|
-375.79%
|
-39.75%
|
-349.9%
|
53.2%
|
46.63%
|
EPS
2 |
1.000
|
-2.700
|
-3.300
|
-3.200
|
-0.9000
|
2.050
|
3.720
|
5.600
|
Free Cash Flow
1 |
5.529
|
-11.67
|
-22.06
|
-19.6
|
-
|
8.8
|
27
|
41.1
|
FCF margin
|
10.25%
|
-143.52%
|
-322.83%
|
-323.62%
|
-
|
47.06%
|
54%
|
47.79%
|
FCF Conversion (EBITDA)
|
51.43%
|
-
|
-
|
-
|
-
|
85.44%
|
103.45%
|
93.41%
|
FCF Conversion (Net income)
|
72.61%
|
-
|
-
|
-
|
-
|
60.27%
|
101.5%
|
102.49%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/12/19
|
3/12/20
|
3/18/21
|
4/19/22
|
3/15/23
|
4/24/24
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2020 S2
|
2021 Q1
|
2021 Q2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 S1
|
2022 S2
|
---|
Net sales
|
1.71
|
3.261
|
0.115
|
0.287
|
0.402
|
1.76
|
-
|
7.349
|
10.01
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
-4.82
|
-
|
-4.86
|
-4.86
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-1,679.44%
|
-
|
-276.14%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-5.3
|
-
|
-6.08
|
-6.08
|
-
|
-
|
Net income
1 |
-12.99
|
-
|
-
|
-5.3
|
-
|
-6.08
|
-6.08
|
4.252
|
-
|
Net margin
|
-759.88%
|
-
|
-
|
-1,846.69%
|
-
|
-345.45%
|
-
|
57.86%
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-0.8600
|
-
|
-
|
-1.400
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/17/19
|
3/18/21
|
4/22/21
|
7/22/21
|
7/22/21
|
4/27/22
|
4/19/22
|
9/19/22
|
3/15/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
0.08
|
19.3
|
-
|
3.3
|
-
|
-
|
Net Cash position
1 |
32.7
|
22.5
|
-
|
-
|
-
|
-
|
22.5
|
62.3
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.003997
x
|
-
|
-
|
0.3204
x
|
-
|
-
|
Free Cash Flow
1 |
5.53
|
-11.7
|
-22.1
|
-19.6
|
-
|
8.8
|
27
|
41.1
|
ROE (net income / shareholders' equity)
|
18.4%
|
-50.4%
|
-136%
|
-
|
-
|
-
|
-
|
75.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
6.610
|
4.030
|
0.9100
|
-
|
-
|
0.4800
|
2.400
|
5.280
|
Cash Flow per Share
|
1.070
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.78
|
2.02
|
0.21
|
0.36
|
-
|
0.4
|
1
|
1.7
|
Capex / Sales
|
1.45%
|
24.82%
|
3%
|
5.96%
|
-
|
2.14%
|
2%
|
1.98%
|
Announcement Date
|
3/12/19
|
3/12/20
|
3/18/21
|
4/19/22
|
3/15/23
|
4/24/24
|
-
|
-
|
Last Close Price
8.43
EUR Average target price
9.7
EUR Spread / Average Target +15.07% Consensus |
1st Jan change
|
Capi.
|
---|
| -26.95% | 129M | | -2.31% | 103B | | +0.56% | 95.28B | | +1.69% | 22.15B | | -17.37% | 21.02B | | -9.30% | 18.15B | | -41.01% | 16.74B | | -14.85% | 16.05B | | +3.21% | 13.68B | | +33.54% | 12.17B |
Bio Therapeutic Drugs
|